<p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Pretreatment of aorta with cyclooxygenase inhibitor; indomethacin (92.95%&#8201;&#177;&#8201;2.73; <italic>p</italic>&#8201;&gt;&#8201;0.05) did not produce any significant difference of vasorelaxation induced by AcEO precontracted with phenylephrine. Therefore, aorta preincubated with endoplasmic reticulum calcium-ATPase inhibitor; thapsigargin (45.34%&#8201;&#177;&#8201;6.58; <italic>p</italic>&#8201;&lt;&#8201;0.001), and calcium channel type VOC blocker; verapamil (48.12%&#8201;&#177;&#8201;8.21; <italic>p</italic>&#8201;&lt;&#8201;0.001) produced a sub-maximum inhibitory effect of vasorelaxation induced by AcEO (0.1&#8211;100&#160;&#956;g/ml) (Figs.&#160;<xref rid="Fig6" ref-type="fig">6b</xref> and <xref rid="Fig7" ref-type="fig">7</xref>).<fig id="Fig7"><label>Fig. 7</label><caption><p>Original tracing showing the vasorelaxant effect of <italic>A. campestris</italic> L. essential oil (AcEO) on isolated aorta pre-contracted with Phen 1&#160;&#956;M (<bold>a</bold>) and in the presence of Verapamil (<bold>b</bold>) and Thapsigargin (<bold>c</bold>)</p></caption><graphic xlink:href="12906_2017_1598_Fig7_HTML" id="MO7"/></fig>
</p>